These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 9721794)

  • 1. Depletion of natural killer cells from the graft reduces interferon-gamma levels and lipopolysaccharide-induced tumor necrosis factor-alpha release in F1 hybrid mice with acute graft-versus-host disease.
    Ellison CA; HayGlass KT; Fischer JM; Rector ES; MacDonald GC; Gartner JG
    Transplantation; 1998 Aug; 66(3):284-94. PubMed ID: 9721794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GVHD-associated enteropathy and endotoxemia in F1-hybrid recipients of NK1.1-depleted grafts.
    Ellison CA; Amadeo RJ; Gartner JG
    Scand J Immunol; 2001 Oct; 54(4):375-82. PubMed ID: 11555404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gamma delta T cells in the pathobiology of murine acute graft-versus-host disease. Evidence that gamma delta T cells mediate natural killer-like cytotoxicity in the host and that elimination of these cells from donors significantly reduces mortality.
    Ellison CA; MacDonald GC; Rector ES; Gartner JG
    J Immunol; 1995 Nov; 155(9):4189-98. PubMed ID: 7594574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Graft-versus-host disease in recipients of grafts from natural killer T cell-deficient (Jalpha281(-/-)) donors.
    Ellison CA; Taniguchi M; Fischer JM; Hayglass KT; Gartner JG
    Immunology; 2006 Nov; 119(3):338-47. PubMed ID: 16879624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A role for CD4+ NK1.1+ T lymphocytes as major histocompatibility complex class II independent helper cells in the generation of CD8+ effector function against intracellular infection.
    Denkers EY; Scharton-Kersten T; Barbieri S; Caspar P; Sher A
    J Exp Med; 1996 Jul; 184(1):131-9. PubMed ID: 8691126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unconventional NK1.1(-) intermediate TCR cells as major T lymphocytes expanding in chronic graft-versus-host disease.
    Miyakawa R; Miyaji C; Watanabe H; Yokoyama H; Tsukada C; Asakura H; Abo T
    Eur J Immunol; 2002 Sep; 32(9):2521-31. PubMed ID: 12207336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of interferon-gamma, nitric oxide and lipopolysaccharide in intestinal graft-versus-host disease developing in F1-hybrid mice.
    Ellison CA; Natuik SA; McIntosh AR; Scully SA; Danilenko DM; Gartner JG
    Immunology; 2003 Jul; 109(3):440-9. PubMed ID: 12807491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of intrahepatic CD8+ T cell trapping and NK1.1+ cells in liver-mediated immune regulation.
    Shibolet O; Alper R; Zolotarov L; Trop S; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
    Clin Immunol; 2004 Apr; 111(1):82-92. PubMed ID: 15093555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graft-versus-host disease.
    Nestel FP; Price KS; Seemayer TA; Lapp WS
    J Exp Med; 1992 Feb; 175(2):405-13. PubMed ID: 1732411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Murine graft-versus-host disease in an F1-hybrid model using IFN-gamma gene knockout donors.
    Ellison CA; Fischer JM; HayGlass KT; Gartner JG
    J Immunol; 1998 Jul; 161(2):631-40. PubMed ID: 9670937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killer cell depletion fails to influence initial CD4 T cell commitment in vivo in exogenous antigen-stimulated cytokine and antibody responses.
    Wang M; Ellison CA; Gartner JG; HayGlass KT
    J Immunol; 1998 Feb; 160(3):1098-105. PubMed ID: 9570522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow NK1.1(-) and NK1.1(+) T cells reciprocally regulate acute graft versus host disease.
    Zeng D; Lewis D; Dejbakhsh-Jones S; Lan F; García-Ojeda M; Sibley R; Strober S
    J Exp Med; 1999 Apr; 189(7):1073-81. PubMed ID: 10190898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Th1 cytokines and NK cells participate in the development of murine syngeneic graft-versus-host disease.
    Flanagan DL; Jennings CD; Bryson JS
    J Immunol; 1999 Aug; 163(3):1170-7. PubMed ID: 10415011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute, lethal graft-versus-host disease in an F1-hybrid model using grafts from parental-strain, T-cell receptor-delta gene knockout donors.
    Ellison C; Gartner J
    Scand J Immunol; 1998 Sep; 48(3):272-6. PubMed ID: 9743212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The NK1.1 antigen in NK-mediated F1 antiparent killing in vitro.
    Kung SK; Miller RG
    J Immunol; 1995 Feb; 154(4):1624-33. PubMed ID: 7836747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A population of CD62Llow Nk1.1- CD4+ T cells that resembles NK1.1+ CD4+ T cells.
    Chen H; Paul WE
    Eur J Immunol; 1998 Oct; 28(10):3172-82. PubMed ID: 9808186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of NK1.1(+) T cells as well as NK cells against intraperitoneal tumors in mice.
    Kawamura T; Seki S; Takeda K; Narita J; Ebe Y; Naito M; Hiraide H; Abo T
    Cell Immunol; 1999 May; 193(2):219-25. PubMed ID: 10222065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the phenotype and function of CD8(+), alpha / beta(+) NKT cells from tumor-bearing mice that show a natural killer cell activity and lyse multiple tumor targets.
    Stremmel C; Exley M; Balk S; Hohenberger W; Kuchroo VK
    Eur J Immunol; 2001 Sep; 31(9):2818-28. PubMed ID: 11536181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance of CD7-deficient mice to lipopolysaccharide-induced shock syndromes.
    Sempowski GD; Lee DM; Scearce RM; Patel DD; Haynes BF
    J Exp Med; 1999 Mar; 189(6):1011-6. PubMed ID: 10075985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance of natural killer T cell-deficient mice to systemic Shwartzman reaction.
    Dieli F; Sireci G; Russo D; Taniguchi M; Ivanyi J; Fernandez C; Troye-Blomberg M; De Leo G; Salerno A
    J Exp Med; 2000 Dec; 192(11):1645-52. PubMed ID: 11104806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.